Editorial: is age just a number when it comes to treatment of inflammatory bowel disease? Authors' reply

Aliment Pharmacol Ther. 2020 Nov;52(10):1617-1618. doi: 10.1111/apt.16106.

Authors

Vera E R Asscher¹, Vince B C Biemans^{2

3}, Frank Hoentjen², P W Jeroen Maljaars¹; Dutch Initiative on Crohn and Colitis (ICC)

Affiliations

¹ Leiden University Medical Centre, Leiden, The Netherlands.
² Radboud University Medical Centre, Nijmegen, The Netherlands.
³ Maastricht University Medical Centre, Maastricht, The Netherlands.

PMID: 33085982
DOI: 10.1111/apt.16106

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Cohort Studies
Comorbidity
Humans
Inflammatory Bowel Diseases* / drug therapy
Prospective Studies
Ustekinumab*

Substances

Antibodies, Monoclonal, Humanized
vedolizumab
Ustekinumab